Table 3 Patient Risk Factors at Baseline for Visual Impairment
From: Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy
Risk of Visual Impairment > 0.3logMAR | Risk of Visual Impairment ≥1.0 logMAR | |||
|---|---|---|---|---|
OR (95%CI) | p (0.05) | p (0.05) | ||
Demographics | ||||
Age at uveitis diagnosis | 0.97 (0.87–1.08) | 0.56 | 1.02 (0.88–1.19) | 0.76 |
Bilateral Disease | 1.23 (0.46–3.34) | 0.68 | 0.45 (0.12–1.65) | 0.23 |
Female | 1.43 (0.61–3.36) | 0.41 | 1.24 (0.38–4.12) | 0.72 |
Tertiary Referral | 2.71 (1.12–6.56) | 0.03 | 4.59 (0.98–21.47) | 0.05 |
Aetiology | ||||
JIA | 2.05 (0.88–4.77) | 0.10 | 2.15 (0.62–7.43) | 0.23 |
Idiopathic | 0.54 (0.23–1.29) | 0.16 | 0.23 (0.05–1.09) | 0.07 |
Uveitis Characteristics | ||||
Anterior Uveitis | 0.89 (0.37–2.14) | 0.80 | 0.89 (0.26–3.07) | 0.85 |
Bilateral Disease | 1.23 (0.46–3.34) | 0.68 | 0.45 (0.12–1.65) | 0.23 |
Complications at Baseline | ||||
Band keratopathy | 1.24 (0.24–6.37) | 0.80 | 1.12 (0.15–8.53) | 0.92 |
Cataracts | 1.43 (0.29–6.99) | 0.66 | 5.16 (0.91–29.23) | 0.06 |
Posterior synechiae | 0.84 (0.26–2.71) | 0.77 | 4.91 (1.38–17.39) | 0.01 |
Elevated IOP | 0.35 (0.05–2.51) | 0.29 | 1.00 | |
Macular oedema | 1.09 (0.12–10.07) | 0.94 | 1.00 | |
Hypotony | 2.20 (0.19–25.31) | 0.53 | 7.08 (0.64–78.00) | 0.11 |
Optic disc swelling | 0.98 (0.29–3.30) | 0.97 | 2.05 (0.47–8.88) | 0.34 |